Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.5K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.5K
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

285
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
285
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

402
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
402
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

469
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
469

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of Optic Nerve Pit-associated Macular Detachment with Pars Plana Vitrectomy Combined with Multilayered ILM Optic Pit Plug and Heavy Silicone Oil.

Klinische Monatsblatter fur Augenheilkunde·2026
Same author

Observation of Corneal Nerve Regeneration after Oxervate Treatment with Confocal Microscopy - A Clinical Case.

Klinische Monatsblatter fur Augenheilkunde·2026
Same author

Between Scylla and Charybdis?-Health insurance claims-data to monitor quality of service delivery in ophthalmology.

Eye (London, England)·2024
Same author

Protracted Intralenticular Implant of Sustained-Release Dexamethasone Implant (Ozurdex).

Klinische Monatsblatter fur Augenheilkunde·2024
Same author

Silicone Oil Tamponade for Therapy of Primary Retinal Detachment in Patients Who Live at High Altitudes.

Klinische Monatsblatter fur Augenheilkunde·2024
Same author

Acute Myopic Shift after a Single Dose of Acetazolamide: A Case Report and Review of the Literature.

Klinische Monatsblatter fur Augenheilkunde·2024
Same journal

Erratum.

Developments in ophthalmology·2021
Same journal

Pediatric Vitreoretinal Surgery and Integrated Intraoperative Optical Coherence Tomography.

Developments in ophthalmology·2021
Same journal

Integrated Intraoperative Optical Coherence Tomography for Pediatric Lamellar Corneal Transplant Surgery.

Developments in ophthalmology·2021
Same journal

The Use of Optical Coherence Tomography as an Intraoperative Adjunct of Oculoplastic Surgery.

Developments in ophthalmology·2021
Same journal

Integrated Intraoperative Optical Coherence Tomography in Strabismus Surgery.

Developments in ophthalmology·2021
Same journal

Use of Integrated Intraoperative Ocular Coherence Tomography in Pediatric Cataract Surgery: Thinking outside the Box.

Developments in ophthalmology·2021
See all related articles

Related Experiment Video

Updated: Mar 5, 2026

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
10:24

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

10.9K

Macular Edema - Rationale for Therapy.

Thomas J Wolfensberger1

  • 1Jules Gonin Eye Hospital, Department of Ophthalmology, University of Lausanne, Lausanne, Switzerland.

Developments in Ophthalmology
|March 29, 2017
PubMed
Summary
This summary is machine-generated.

Macular edema treatments target underlying causes and cellular mechanisms. Novel therapies and surgical interventions offer future promise for retinal health and vision preservation.

More Related Videos

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

22.3K
Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases
07:36

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases

Published on: July 3, 2025

820

Related Experiment Videos

Last Updated: Mar 5, 2026

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
10:24

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

10.9K
Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

22.3K
Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases
07:36

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases

Published on: July 3, 2025

820

Area of Science:

  • Ophthalmology
  • Retinal Diseases
  • Vascular Biology

Background:

  • Macular edema is a severe condition resulting from various ocular and systemic diseases.
  • Understanding pathophysiological pathways is crucial for effective clinical treatment.
  • Both generalized health issues (diabetes, hypertension) and ocular diseases contribute to macular edema.

Purpose of the Study:

  • To review the pathophysiological mechanisms of macular edema.
  • To discuss current pharmacological and surgical treatment strategies.
  • To explore emerging therapeutic approaches for retinal health.

Main Methods:

  • Review of current clinical treatments for macular edema.
  • Analysis of the role of Starling's law and blood-retinal barrier in fluid exudation.
  • Exploration of novel therapeutic agents and surgical techniques.

Main Results:

  • Current drugs (NSAIDs, corticosteroids, anti-VEGF) target cellular mechanisms.
  • New treatments focus on neuroprotection and anti-apoptosis pathways.
  • Surgical interventions like vitrectomy activate beneficial cellular and biochemical processes.

Conclusions:

  • Effective macular edema management requires addressing both systemic and ocular factors.
  • Pharmacological and surgical treatments modulate key cellular pathways.
  • Emerging therapies hold potential for improved outcomes in retinal disease management.